Dr. Anosh Agarwal has officially disclosed the transfer of 14,85,822 equity shares in Dr. Agarwal’s Health Care Limited to Dr. Athiya Agarwal. This transfer, executed on February 24, 2026, was classified as an inter-se off-market transfer between promoters by way of a gift. Following the transaction, the transferred shares represent 0.47% of the total voting capital, resulting in Dr. Athiya Agarwal’s new holding being 5.36%.
Disclosure of Promoter Share Transfer
An official disclosure has been made concerning a significant change in the shareholding pattern of Dr. Agarwal’s Health Care Limited. The announcement, dated February 26, 2026, details an inter-se transfer of equity shares between existing promoters, executed by way of a gift.
Transaction Details
The key parties involved are:
- Transferor: Dr. Anosh Agarwal
- Acquirer: Dr. Athiya Agarwal
The mode of transaction was an Inter-se off-market transfer of shares between promoter/promoter group by way of gift. The effective date of the acquisition/sale was February 24, 2026.
Impact on Shareholding Before Transfer
Prior to this transaction, Dr. Anosh Agarwal held:
- Shares carrying voting rights: 1,84,58,922 equity shares.
- This represented 5.83% of the total share/voting capital.
Details of Acquisition/Sale
The number of shares transferred (acquired/sold) by way of gift is detailed below:
- Shares carrying voting rights acquired/sold: 14,85,822 shares.
- This equates to 0.47% of the total share capital.
- Total shares transferred (e): 14,85,822, or 0.47%.
Post-Transfer Holding
Following the completion of the gift transfer, the new holding structure for Dr. Athiya Agarwal is:
- Shares carrying voting rights: 1,69,73,100 shares.
- This new holding represents 5.36% of the total voting capital.
Capital Structure Context
The context for these percentages is based on the following capital base:
- Equity share capital before the said acquisition/sale: 31,68,07,506 equity shares of Re. 1/- each.
- Equity share capital after the said acquisition/sale: Remains 31,68,07,506 equity shares of Re. 1/- each, confirming the transaction was purely an internal transfer without changes to the company’s issued capital.
The disclosure was signed by Dr. Anosh Agarwal from Chennai.
Source: BSE
